Earnings Call · Q2 FY2026·2026-08-10

Q2 26EPS 0.00%·Rev n/aQ1 26EPS +53.85%·Rev n/aQ4 25EPS -100.00%*·Rev n/aQ3 25EPS +4.17%·Rev n/a⚠ consensus missing

Insight Molecular Diagnostics Inc. IMDX

Cathy — Head of Investor Relations

Josh Riggs — Chief Executive Officer

Andrea James — Chief Financial Officer

−7.1%1d on move date3d−22.2%5d−10.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IMDX calls or request research access.

More IMDX calls Browse calls Request research access